VANCOUVER, BC — (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”), a Canadian clinical stage pharmaceutical development company, announces a non-brokered private… Read More
Conditional approval based on data from Phase 3 PROpel trial MISSISSAUGA, ON — Health Canada has granted a Notice of Compliance with Conditions (NOC/c) for Lynparza® (olaparib) in combination with… Read More
VANCOUVER, BC — Virogin Biotech announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of VG161 for patients with advanced unresectable Hepatocellular… Read More
NanoAssemblr combines scalable mixing technology to deliver seamless formulation of lipid nanoparticle medicines from clinical development to large-scale commercial manufacturing. Single-use fluid path reduces the risk of cross-contamination, supports efficient… Read More
WELL has completed the acquisition of Atlanta based CarePlus Management (“CarePlus“) through its CRH Medical subsidiary. The acquisition of CarePlus provides CRH with a platform for provider recruitment and locum… Read More
